
Rebyota
My Prescription
Payment
Select pharmacy




$9,702.04
$30.00 due at pharmacy
$9,702.04 - $30.00 = $9,672.04
$9,672.04 remaining balance
You will be given your coupon after you complete your purchase with PayPal.
$9,702.04
Print or send this coupon to your phone
About Rebyota
Drug Details
Rebyota is a treatment designed to prevent the recurrence of Clostridioides difficile (C. diff) infection in adults after the initial infection has been addressed. This therapy involves a rectal administration of a solution containing fecal microbiota, sourced from carefully screened donors. It works by reintroducing a healthy balance of microbes into the gut, which supports overall digestive health and reduces the risk of further infections. While Rebyota is not intended to treat an active C. diff infection, it can alleviate symptoms such as diarrhea, nausea, and stomach discomfort associated with previous infections. Some users may experience side effects like stomach pain and bloating. Always consult with a healthcare provider for personalized advice and to ensure safe and effective use of this treatment.
Price history for Rebyota
1 Box, 150ML of 150ML
Average retail price for Rebyota
Average SaveHealth price for Rebyota
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Rebyota dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 150ML of 150ML | 1 Box | $9,702.04 | $9,702.04 |
| 150ML of 150ML | 2 Boxes | $19,380.77 | $9,690.39 |
| 150ML of 150ML | 3 Boxes | $29,059.51 | $9,686.50 |
Rebyota FAQs
Rebyota is used for the prevention of recurrent Clostridioides difficile infection (CDI) in individuals who are 18 years of age and older, following antibiotic treatment for recurrent CDI.
Yes, Rebyota is a type of fecal microbiota transplantation (FMT) product. It is used to restore healthy gut bacteria in patients, particularly for the prevention of recurrent Clostridioides difficile infection.
Rebyota has shown a success rate of approximately 70.6% in preventing recurrent Clostridioides difficile infection (CDI) in clinical trials. This rate reflects its effectiveness in reducing the recurrence of CDI after initial treatment.
Yes, Rebyota is a form of fecal microbiota transplantation (FMT). It is used to restore healthy gut bacteria in patients, particularly for the prevention of recurrent Clostridioides difficile infection.
The cost of Rebyota can vary depending on factors such as the healthcare provider, location, and insurance coverage. It is recommended to contact a healthcare provider or pharmacy for the most accurate and up-to-date pricing information. Additionally, checking with insurance providers can help determine if the treatment is covered under a specific plan.